Longitudinal biomarker analyses indicate that Flt-1 and IL-15 are elevated within CSF at preclinical, prodromal, and dementia stages of Alzheimer’s disease, and are associated with cortical thinning and subsequent cognitive decline36. This evidence concerns the gene IL15 and early-onset autosomal dominant Alzheimer disease.